Realbotix announces the sale of subsidiary to Onconetix
Source: SeekingAlpha
2026-02-12 08:45:22 ET
More on Realbotix, Oncology Medical
- Seeking Alpha’s Quant Rating on Realbotix
- Historical earnings data for Realbotix
- Financial information for Realbotix
- Seeking Alpha’s Quant Rating on Oncology Medical
- Financial information for Oncology Medical
Read the full article on Seeking Alpha
For further details see:
Realbotix announces the sale of subsidiary to Onconetix
Onconetix Inc.
NASDAQ: ONCO
ONCO Trading
2.46% G/L:
$0.6661 Last:
14,430 Volume:
$0.66 Open:
ONCO Latest News
February 12, 2026 08:00:00 am
Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company
February 12, 2026 08:00:00 am
Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer
October 07, 2025 08:00:00 am
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
ONCO Stock Data
$2,348,073
1,259,562
0.17%
5
N/A
Biotechnology & Life Sciences
Healthcare
US
Cincinnati
